Search research articles
Contact Us
Filters
Showing results (91-100 of 122) with videos related to
Page
of 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
October 31, 2008
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
Sven Rottenberg, Janneke E Jaspers, Ariena Kersbergen, et al.
Oncogene
|
December 17, 2025
MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors
Hülya Dogan, Martin Liptay, Joana S Barbosa, et al.
Cancer Research Communications
|
December 5, 2022
Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy
Carmen A Widmer, Ismar Klebic, Natalya Domanitskaya, et al.
Cancer Research
|
August 24, 2016
The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models
Lenka Oplustil O'Connor, Stuart L Rulten, Aaron N Cranston, et al.
Biorxiv : the Preprint Server for Biology
|
August 2, 2024
Deep Learning-based Modeling for Preclinical Drug Safety Assessment
Guillaume Jaume, Simone de Brot, Andrew H Song, et al.
British Journal of Cancer
|
June 12, 2024
Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1)
S Lot Aronson, Cédric Walker, Bram Thijssen, et al.
The EMBO Journal
|
November 5, 2015
Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs
Rosa Planells-Cases, Darius Lutter, Charlotte Guyader, et al.
Molecular Cell
|
January 18, 2016
HELB Is a Feedback Inhibitor of DNA End Resection
Ján Tkáč, Guotai Xu, Hemanta Adhikary, et al.
Cancer Research
|
July 16, 2010
6-thioguanine selectively kills BRCA2-defective tumors and overcomes PARP inhibitor resistance
Natalia Issaeva, Huw D Thomas, Tatjana Djureinovic, et al.
Cell Reports
|
August 27, 2020
Functional Radiogenetic Profiling Implicates ERCC6L2 in Non-homologous End Joining
Paola Francica, Merve Mutlu, Vincent A Blomen, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 122) with videos related to
Sort By:
Page
of 13
Proceedings of the National Academy of Sciences of the United States of America
|
October 31, 2008
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
Sven Rottenberg, Janneke E Jaspers, Ariena Kersbergen, et al.
Oncogene
|
December 17, 2025
MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors
Hülya Dogan, Martin Liptay, Joana S Barbosa, et al.
Cancer Research Communications
|
December 5, 2022
Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy
Carmen A Widmer, Ismar Klebic, Natalya Domanitskaya, et al.
Cancer Research
|
August 24, 2016
The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models
Lenka Oplustil O'Connor, Stuart L Rulten, Aaron N Cranston, et al.
Biorxiv : the Preprint Server for Biology
|
August 2, 2024
Deep Learning-based Modeling for Preclinical Drug Safety Assessment
Guillaume Jaume, Simone de Brot, Andrew H Song, et al.
British Journal of Cancer
|
June 12, 2024
Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1)
S Lot Aronson, Cédric Walker, Bram Thijssen, et al.
The EMBO Journal
|
November 5, 2015
Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs
Rosa Planells-Cases, Darius Lutter, Charlotte Guyader, et al.
Molecular Cell
|
January 18, 2016
HELB Is a Feedback Inhibitor of DNA End Resection
Ján Tkáč, Guotai Xu, Hemanta Adhikary, et al.
Cancer Research
|
July 16, 2010
6-thioguanine selectively kills BRCA2-defective tumors and overcomes PARP inhibitor resistance
Natalia Issaeva, Huw D Thomas, Tatjana Djureinovic, et al.
Cell Reports
|
August 27, 2020
Functional Radiogenetic Profiling Implicates ERCC6L2 in Non-homologous End Joining
Paola Francica, Merve Mutlu, Vincent A Blomen, et al.
Page
of 13